Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML

10.1182/blood-2008-05-156422

Saved in:

Bibliographic Details
Main Authors:	Zhou, J., Bi, C., Janakakumara, J.V., Liu, S.-C., Chng, W.-J., Tay, K.-G., Poon, L.-F., Xie, Z., Palaniyandi, S., Chen, C.-S., Yu, H., Glaser, K.B., Albert, D.H., Davidsen, S.K.
Other Authors:	PHYSIOLOGY
Format:	Article
Published:	2011
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/26991
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-26991
record_format	dspace
spelling	sg-nus-scholar.10635-269912023-10-29T22:09:02Z Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML Zhou, J. Bi, C. Janakakumara, J.V. Liu, S.-C. Chng, W.-J. Tay, K.-G. Poon, L.-F. Xie, Z. Palaniyandi, S. Chen, C.-S. Yu, H. Glaser, K.B. Albert, D.H. Davidsen, S.K. PHYSIOLOGY MEDICINE CANCER SCIENCE INSTITUTE OF SINGAPORE 10.1182/blood-2008-05-156422 Blood 113 17 4052-4062 2011-09-27T05:43:32Z 2011-09-27T05:43:32Z 2009 Article Zhou, J., Bi, C., Janakakumara, J.V., Liu, S.-C., Chng, W.-J., Tay, K.-G., Poon, L.-F., Xie, Z., Palaniyandi, S., Chen, C.-S., Yu, H., Glaser, K.B., Albert, D.H., Davidsen, S.K. (2009). Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML. Blood 113 (17) : 4052-4062. ScholarBank@NUS Repository. https://doi.org/10.1182/blood-2008-05-156422 00064971 15280020 http://scholarbank.nus.edu.sg/handle/10635/26991 000265447000025 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.1182/blood-2008-05-156422
author2	PHYSIOLOGY
author_facet	PHYSIOLOGY Zhou, J. Bi, C. Janakakumara, J.V. Liu, S.-C. Chng, W.-J. Tay, K.-G. Poon, L.-F. Xie, Z. Palaniyandi, S. Chen, C.-S. Yu, H. Glaser, K.B. Albert, D.H. Davidsen, S.K.
format	Article
author	Zhou, J. Bi, C. Janakakumara, J.V. Liu, S.-C. Chng, W.-J. Tay, K.-G. Poon, L.-F. Xie, Z. Palaniyandi, S. Chen, C.-S. Yu, H. Glaser, K.B. Albert, D.H. Davidsen, S.K.
spellingShingle	Zhou, J. Bi, C. Janakakumara, J.V. Liu, S.-C. Chng, W.-J. Tay, K.-G. Poon, L.-F. Xie, Z. Palaniyandi, S. Chen, C.-S. Yu, H. Glaser, K.B. Albert, D.H. Davidsen, S.K. Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
author_sort	Zhou, J.
title	Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
title_short	Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
title_full	Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
title_fullStr	Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
title_full_unstemmed	Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
title_sort	enhanced activation of stat pathways and overexpression of survivin confer resistance to flt3 inhibitors and could be therapeutic targets in aml
publishDate	2011
url	http://scholarbank.nus.edu.sg/handle/10635/26991
_version_	1781410553738035200

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML

Similar Items